At 14:30 IST, the barometer index, the S&P BSE Sensex tumbled 661.91 points or 0.80% to 81,840.85. The Nifty 50 index dropped 218.45 points or 0.87% to 25,037.70.
These Are Boom Times for ‘Degrowth’ (04-10-2024)
The term has recently begun taking root in popular culture and policy.
Volumes soar at Avenue Supermarts Ltd counter (04-10-2024)
Avenue Supermarts Ltd clocked volume of 26.06 lakh shares by 14:14 IST on NSE, a 5.3 times surge over two-week average daily volume of 4.92 lakh shares
Promoter dilution in small, midcaps surges (04-10-2024)
The controlling shareholders of smaller and mid-sized companies are reducing their stakes at levels seldom seen since the 2008 global financial crisis. Over 20 per cent of companies listed on BSE MidCap and BSE SmallCap have seen a decline in promoter holdings for five consecutive quarters, reveals data from DSP Mutual Fund, shared with Business Standard. In the latest June quarter, the figure stood at 22.6 per cent.
Indoco Remedies receives USFDA approval for Cetirizine Hydrochloride Tablets (04-10-2024)
Indoco Remedies (Indoco) announced the receipt of final approval from the USFDA for Abbreviated New Drug Application (ANDA) for Cetirizine Hydrochloride Tablets USP, 10 mg (OTC), a generic equivalent of the Reference Listed Drug, Zyrtec Allergy Tablets, 10 mg of Johnson & Johnson Consumer Inc.
Deep Industries (DIL) (04-10-2024)
Deep Industries operates in a cyclical industry, with its revenue and profitability fluctuating based on global oil and gas prices, economic activity, and the energy sector’s capital investments. Therefore, its stock performance and financials can also exhibit cyclicality, with periods of strong growth followed by contractions
IPO calendar next week: 7 issues to garner investors attention; Full list (04-10-2024)
This week saw the successful listing of three mainline IPOs – KRN Heat Exchanger, Diffusion Engineers, and Manba Finance – setting the stage for another promising week ahead for investors